

Access and Utilization of New Antidepressant and Antipsychotic Medications. A. New Chemical Entities and Generic Competition
The entry of new chemical entities into the psychotherapeutic market in the coming years will profoundly alter the dynamics shaping access to and utilization of these products in much the same way the launch of the current generation of products changed the market within the last decade. It can be expected that these products will be launched with